Search research articles
Contact Us
Filters
Showing results (151-160 of 162) with videos related to
Page
of 17
Sort By:
Cancer Gene Therapy
|
August 15, 2015
Inhibition of the Aurora A kinase augments the anti-tumor efficacy of oncolytic measles virotherapy
I D Iankov, C B Kurokawa, A B D'Assoro, et al.
Cancer
|
April 3, 1999
A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma
J N Ingle, V J Suman, C G Kardinal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 16, 2002
A randomized phase II study of sequential docetaxel and doxorubicin/cyclophosphamide in patients with metastatic breast cancer
E A Perez, L Geeraerts, V J Suman, et al.
Breast Cancer Research and Treatment
|
January 12, 2011
A randomized, placebo-controlled trial (NCIC CTG MAP.2) examining the effects of exemestane on mammographic breast density, bone density, markers of bone metabolism and serum lipid levels in postmenopausal women
T Cigler, H Richardson, M J Yaffe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 21, 1998
Multicenter randomized clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive metastatic breast cancer: an intergroup study
C W Taylor, S Green, W S Dalton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 3, 2012
Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole
P E Goss, J N Ingle, S Martino, et al.
Radiology
|
February 1, 1997
Accelerated hyperfractionation radiation therapy after lumpectomy and axillary lymph node dissection in patients with stage I or II breast cancer: pilot study
P J Schomberg, T G Shanahan, J N Ingle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 6, 2017
Impact of baseline BMI and weight change in CCTG adjuvant breast cancer trials
R Yerushalmi, B Dong, J W Chapman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 12, 2008
Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17
J N Ingle, D Tu, J L Pater, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 28, 2023
Genomic characterisation of hormone receptor-positive breast cancer arising in very young women
S J Luen, G Viale, S Nik-Zainal, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 162) with videos related to
Sort By:
Page
of 17
Cancer Gene Therapy
|
August 15, 2015
Inhibition of the Aurora A kinase augments the anti-tumor efficacy of oncolytic measles virotherapy
I D Iankov, C B Kurokawa, A B D'Assoro, et al.
Cancer
|
April 3, 1999
A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma
J N Ingle, V J Suman, C G Kardinal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 16, 2002
A randomized phase II study of sequential docetaxel and doxorubicin/cyclophosphamide in patients with metastatic breast cancer
E A Perez, L Geeraerts, V J Suman, et al.
Breast Cancer Research and Treatment
|
January 12, 2011
A randomized, placebo-controlled trial (NCIC CTG MAP.2) examining the effects of exemestane on mammographic breast density, bone density, markers of bone metabolism and serum lipid levels in postmenopausal women
T Cigler, H Richardson, M J Yaffe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 21, 1998
Multicenter randomized clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive metastatic breast cancer: an intergroup study
C W Taylor, S Green, W S Dalton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 3, 2012
Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole
P E Goss, J N Ingle, S Martino, et al.
Radiology
|
February 1, 1997
Accelerated hyperfractionation radiation therapy after lumpectomy and axillary lymph node dissection in patients with stage I or II breast cancer: pilot study
P J Schomberg, T G Shanahan, J N Ingle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 6, 2017
Impact of baseline BMI and weight change in CCTG adjuvant breast cancer trials
R Yerushalmi, B Dong, J W Chapman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 12, 2008
Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17
J N Ingle, D Tu, J L Pater, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 28, 2023
Genomic characterisation of hormone receptor-positive breast cancer arising in very young women
S J Luen, G Viale, S Nik-Zainal, et al.
Page
of 17